Tuakli-Wosornu et al., 2019 - Google Patents
Medical Issues, Pharmacology and Nutrient InteractionTuakli-Wosornu et al., 2019
- Document ID
- 17424934055989536902
- Author
- Tuakli-Wosornu Y
- Naushad N
- Laar A
- Townsend C
- Lin E
- Publication year
- Publication venue
- Sports Nutrition for Paralympic Athletes, Second Edition
External Links
Snippet
All athletes benefit from nutrient-rich diets with adequate calories to support the increased energy and nutrient demands of athletic training. However, for Paralympic athletes, optimizing impairment-specific health maintenance, sports performance and recovery may …
- 230000003993 interaction 0 title abstract description 30
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bisht et al. | A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue | |
Mirakhori et al. | Diagnosis and treatment methods in Alzheimer's patients based on modern techniques: The orginal article | |
Newbury et al. | Malnutrition in older people: screening and management strategies | |
Niitsu et al. | Effects of combination of whey protein intake and rehabilitation on muscle strength and daily movements in patients with hip fracture in the early postoperative period | |
Spin-Neto et al. | Homeopathic Symphytum officinale increases removal torque and radiographic bone density around titanium implants in rats | |
Sakisaka et al. | A clinical study of ninjin'yoeito with regard to frailty | |
Jazayeri-Tehrani et al. | The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial | |
Calvani et al. | Diet for the prevention and management of sarcopenia | |
US9468659B2 (en) | Nutraceutical supplement with Lactobacillus rhamnosus | |
JP2017535289A (en) | Dietary supplements containing Lactobacillus rhamnosus | |
Nishioka et al. | The concept of aggressive nutrition therapy and clinical indication: A position paper | |
Maker-Clark et al. | Integrative therapies for multiple sclerosis | |
Chen | Guidelines for medical nutrition treatment of overweight/obesity in China (2021) | |
Parry et al. | Can dietary supplements improve a clinician’s well-being and health? | |
Tuakli-Wosornu et al. | Medical Issues, Pharmacology and Nutrient Interaction | |
Weinstein et al. | The stress effect: discover the connection between stress and illness and reclaim your health | |
Kundu et al. | To evaluate the role of homoeopathic medicines as add-on therapy in patients with rheumatoid arthritis on NSAIDs: A retrospective study | |
Mohammadnezhadostad et al. | Investigation Of Nursing And Medical Services In Patients With Diabetes, Abdominal Pain And High Blood Pressure. | |
Fraser et al. | Nutrition issues following spinal cord injury | |
Strupler et al. | 10 Medical Issues, Pharmacology and Nutrient Interactions | |
Prousky | The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis. | |
Doğan et al. | WHY RATIONAL DRUG MANAGEMENT IN AN ELDERLY INDIVIDUAL? | |
Fadlalddin | Association of various concentrations of cat's claw herb (Uncaria tomentosa) on lymphocyte proliferation and nitric oxide expression: An in-vitro study of osteoarthritis | |
JP2006104080A (en) | Composition and health food having prophylactic or therapeutic effect on gout and bloodstream disorder caused by uric acid | |
Schilling | Antibiotic Resistant Bacteria Killed By Teixobactin |